Health Condition 1: M722- Plantar fascial fibromatosis
Conditions
Interventions
Intervention1: Homoeopathic medicines: Homoeopathic medicines in centesimal potencies shall be used in the trial. The selection of the medicine will be based upon totality of symptoms after thorough c
Sponsors
Central council for research in Homoeopathy
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients aged 18 to 65 years 2. Patients of both sexes 3. Diagnosed case of heel pain with plantar fascitis may be unilateral or bilateral 4. Pain in heel (unilateral or bilateral ) in the morning after waking up or first few steps after sitting down or rest for a long time, 5. Local pain and tenderness where the plantar fascia attaches to the heel, 6. Increasing pain in heel with extended walking or standing for more than 15 min. 7. Written Informed consent from the patient. 8. Wash-out period of at least two weeks for any ongoing conventional medicines.
Exclusion criteria
Exclusion criteria: 1. Subjects with diagnosed cases of advanced stage of Metabolic disorders like advanced-stage of Diabetes, CKD, and Cardiovascular diseases. 2. Subjects with Focal neurological diseases. 3. Subjects with impaired lower limb circulation. 4. Subjects with infectious diseases of the lower limb. 5. Subjects with congenital deformities of foot and ankle. 6. Subjects who are on other medications. Pregnant and lactating mother. 7. Subjects not willing to participate in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the outcome of homoeopathic intervention on heel pain and functional ability in patients with plantar fasciitis as measured by the Visual Analogue Scale (VAS) and the Plantar Fasciitis Pain and Disability Scale (PFPS)Timepoint: every 6-week intervals for 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. To evaluate the outcome of homoeopathic intervention on heel pain, general well-being, & quality of life (QoL) using the Outcome Related to Impact on Daily Living (ORDIL) scale 2. To assess the changes in plantar fascia thickness by ultrasonography & in calcaneal spur (if associated with plantar fasciitis) by digital radiography following homoeopathic intervention. Timepoint: 1. ORIDL Scales at 6 week intervals for 6 months. 2. To compare changes in plantar fascia thickness measured by ultrasonography (USG) at baseline & at the end of six months of treatment To compare changes in calcaneal spur assessed by digital radiography at baseline & at the end of six months of treatment | — |
Countries
India
Contacts
Public ContactDr Suraia Parveen
Dr. Anjali Chatterji Regional Research Institute for Homoeopathy
Outcome results
None listed